Plain-English translation of NCT06987643 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing whether , a new oral medication, can help people recover better from moderate to severe ischemic stroke — the kind caused by a blood clot in the brain. Researchers want to see if this medication can improve physical movement and thinking abilities in the weeks and months after stroke. Half of the study participants will receive the actual medication, and half will receive a placebo (a pill with no active ingredient) so researchers can fairly measure how well it works.
After a stroke, many people struggle with lasting problems in movement, strength, and thinking. Current stroke treatments focus on preventing the stroke itself, but there are limited options to help people recover the abilities they've lost. This medication is being tested to see if it can give the brain better tools to repair itself and regain those lost functions.
If you enroll, you will take capsules by mouth three times a day (or twice a day, depending on which study group you're in) for 12 weeks, always with meals. You'll visit the study clinic multiple times so researchers can measure your physical movement, strength, thinking abilities, and overall recovery using standardized tests. Some participants will receive the new medication, while others will receive a placebo — neither you nor the researchers will know which you're taking until the study ends.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Australia